Amrize ltd (AMRZ) has an average monthly price of 58.91, which falls within the 26.5-to-28.1-times P/E ratio range, corresponding to the overvalued zone, indicating a relatively high market valuation. The market is very optimistic about the company’s growth, with strong capital chasing the stock and driving up valuation. This often happens when a company’s fundamentals are hot, the industry is booming, or there’s a short-term story in play. Being in the overvalued zone means expectations are already priced in; if the company misses, the stock could swing or correct hard. Watch revenue, profit, and cash flow to see if fundamentals back up the valuation and to gauge future risk.